Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)

NCT00242489 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1167

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DRUG: MK0663, etoricoxib / Duration of Treatment: Part I (6 weeks), Part II (8 weeks)
DRUG: Placebo;Diclofenac 50mg(tid)/Duration of Treatment: Part I (Placebo) 6 weeks;Part II (Diclofenac) 8 weeks

Sponsor

Organon and Co